Moreover, we observed that 1.73% prevalence of NAT10 mutations (9/517) in LUAD, 1.23% (6/485) in LUSC and 1.35% (138/10156) in all cancer types, respectively (Fig S6b). The gene discussed is NAT10; the disease is cancer.